High prevalence of MTHFR gene A1298C polymorphism in Lebanon

Genetic Testing

Volumn 12, Issue 1, 2008, Pages 75-80

  Sabbagh, Amira S ^a   Mahfoud, Ziyad ^a   Taher, Ali ^a   Zaatari, Ghazi ^a   Daher, Rose ^a   Mahfouz, Rami A R ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HUMAN; LEBANON; MALE; PREVALENCE;

ALLELES; AMINO ACID SUBSTITUTION; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; HUMANS; LEBANON; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 41449106682     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0064     Document Type: Article

References (55)

1. Al-Habboubi H, Tamim H, Ameen G, Almawi WY (2003) A common mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in two Arab communities. J Thromb Haemost 1:2246-2248.
2. Al-Habboubi H, Tamim H, Ameen G, Almawi WY (2004) C677T and A1298C single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene among Bahraini Arabs. Thromb Haemost 91:843-845.
3. Almawi WY, Finan RR, Tamim H, Daccache JL, Irani-Hakime N (2004) Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol 76:85-87.
4. Angeline T, Jeyaraj N, Granito S, Tsongalis GJ (2004) Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. Exp Mol Pathol 77:85-88.
5. Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB (1999) Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 61:265-267.
6. Arruda VR, Siqueira LH, Goncalves MS, von Zuben PM, Soares MC, Menezes R, Annichino-Bizzacchi JM, Costa FF (1998) Prevalence of the mutation C677 → T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78:332-335.
7. Camacho Vanegas O, Giusti B, Restrepo Fernandez CM, Abbate R, Pepe G (1998) Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb Haemost 79:883-884.
8. Chango A, Potier de Courcy G, Boisson F, Guilland JC, Barbe F, Perrin O, Christides JP, Rabhi K, Pfister M, Galun P, Hercberg S, Nicolas JP (2000) 5,10-Methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr 84:891-896.
9. Chiusolo P, Reddiconto G, Cimino G, Sica S, Fiorini A, Farina G, Vitale A, Sora F, Laurenti L, Bartolozzi F, Fazi P, Mandelli F, Leoue G (2004) Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population. Haematologica 89:139-144.
10. D'Angelo A, Mazzola G, Crippa L, Fermo I, Vigano D'Angelo S (1997) Hyperhomocysteinemia and venous thromboembolic disease. Haematologica 82:211-219.
11. de Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, de Stefano V, Margaglione M, Mazzola G, di Minno G, Andria G (1996) Elevated total plasma homocysteine and 677C → T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59:262-264.
12. de Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, Zhu H, Andreasi L, Cama A, Capra V (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319-324.
13. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759-762.
14. Eid SS, Rihani G (2004) Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci 17:200-202.
15. Esfahani ST, Cogger EA, Caudill MA (2003) Heterogeneity in the prevalence of methylene-tetrahydro-folate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 103:200-207.
16. Falchi A, Giovannoni L, Piras IS, Calo CM, Moral P, Vona G, Varesi L (2005) Prevalence of genetic risk factors for coronary artery disease in Corsica Island (France). Exp Mol Pathol 79:210-213.
17. Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA (1998) Analysis of the 677 C → T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 79:119-121.
18. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Baron H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129:1656-1661.
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
20. Gibson CS, MacLennan AH, Rudzki Z, Hague WM, Haan EA, Sharpe P, Priest K, Chan A, Dekker GA, South Australian Cerebral Palsy Research Group (2005). The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology 37:160-163.
21. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G and al. et Department of Cardiology, Adelaide Hospital, Trinity College, Dublin, Ireland (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775-1781.
22. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 136:347-354.
23. Hanson NQ, Aras O, Yang F, Tsai MY (2001) C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47:661-666.
24. Hiraoka M, Kato K, Saito Y, Yasuda K, Kagawa Y (2004) Gene-nutrient and gene-gene interactions of controlled folate intake by Japanese women. Biochem Biophys Res Commun 316:1210-1216.
25. Kahleova R, Palyzova D, Zvara K, Zvarova J, Hrach K, Novakova I, Hyanek J, Bendlova B, Kozich V (2002) Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens 15:857-864.
26. Kang SS, Wong P, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545.
27. Kiffmeyer WR, Langer E, Davies SM, Envall J, Robison LL, Ross JA (2004) Genetic polymorphisms in the Hmong population: implications for cancer etiology and survival. Cancer 100:411-417.
28. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A (1998) Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157:487-492.
29. Kostulas K, Crisby M, Huang WX, Lannfelt L, Hagenfeldt L, Eggertsen G, Kostulas V, Hillert J (1998) A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis. Eur J Clin Invest 28:285-289.
30. Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, Hui R (2002) Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res 106:7-12.
31. Mahfouz RA, Sabbagh AS, Zahed L, Mahfoud ZR, Kalmoni RF, Otrock ZK, Taher AT, Zaatari GS (2006) Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population. Mol Biol Rep 33:145-149.
32. Markan S, Sachdeva M, Sehrawat BS, Kumari S, Jain S, Khullar M (2007) MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem 302:125-131.
33. Mornet E, Muller F, Lenvoise-Furet A, Delezoide AL, Col JY, Simon-Bouy B, Serre JL (1997) Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
34. Mutchinick OM, Lopez MA, Luna L, Waxman J, Babinsky VE (1999) High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 68:461-467.
35. Nishio H, Lee MJ, Fuji M, Kario K, Kayaba K, Shimada K, Matsuo M, Sumino K (1996) A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn J Hum Genet 41:247-251.
36. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP Jr, Adams MJ Jr. (1996) 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
37. Peng F, Labelle LA, Rainey BJ, Tsongalis GJ (2001) Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene are common in U.S. Caucasian and Hispanic American populations. Int J Mol Med 8:509-511.
38. Pepe G, Camacho Vanegas O, Giusti B, Brunelli T, Marcucci R, Attanasio M, Rickards O, De Stefano GF, Prisco D, Geusini GF, Abbate R (1998) Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet 63:917-920.
39. Perez AB, D'Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D (2003) Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 119:20-25.
40. Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H, Matalon RK (1999) Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 86:380-384.
41. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U (2002) The frequent 5,10-methylenetetrahydro-folate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 70:758-762.
42. Rozen R (2003) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523-536.
43. Sabbagh AS, Otrock ZK, Mahfoud ZR, Zaatari GS, Mahfouz RA (2006) Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature. Mol Biol Rep 34:47-52.
44. Sacchi E, Tagliabue L, Duca F, Mannucci PM (1997) High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 78:963-964.
45. Sazci A, Ergul E, Kaya G, Kara I (2005) Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 23:51-54.
46. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, Jin F, Zheng W (2004) MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 13:190-196.
47. Stevenson RE, Schwartz CE, Du YZ, Adams MJ Jr. (1997) Differences in methylene-tetrahydro-folate reductase genotype frequencies, between Whites and Blacks. Am J Hum Genet 60:229-230.
48. Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A (2001) High prevalence of factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 86:723-724.
49. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62:1044-1051.
50. Viel A, Dall'Agnese L, Simone F (1997) Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 75:1105-1110.
51. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172.
52. Wilcken DE, Wang XL, Sim AS, McCredie RM (1996) Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol 16:878-882.
53. Yoo JH, Park SC (2000) Low plasma folate in combination with the 677 C → T methylenetetrahydrofolate reductase polymorphism is associated with increased risk of coronary artery disease in Koreans. Thromb Res 97:77-84.
54. Zaatari G, Otrock Z, Sabbagh AS, Mahfouz RA (2006) Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population. Pathology 38:442-444.
55. Zetterberg H, Coppola A, D'Angelo A, Palmer M, Rymo L, Blennow K (2002) No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease. Thromb Res 108:127-131.